RNU6-794P

Across TCGA pan-cancer cohorts, RNU6-794P RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated RNU6-794P data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher RNU6-794P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-794P expression acts as an unfavorable survival marker, although some lineages such as ACC show a favorable association.

BRCA, ESCA, and LUSC are the cancer types where RNU6-794P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	DFS	Tertile	IV	0.175	0.730	.005	36	view →
ESCA	OS	Tertile	II,III,IV	0.103	0.868	<.001	36	view →
LUSC	OS	Tertile	II,III,IV	0.184	0.631	.007	36	view →
MESO	DFS	Tertile	IV	0.079	0.414	.004	18	view →
OV	DFS	Tertile	III,IV	0.282	0.381	.039	18	view →
SKCM	OS	Tertile	II,III,IV	0.338	0.742	.015	9	view →
CHOL	OS	Tertile	All	0.155	0.725	.029	9	view →
ACC	OS	Tertile	III,IV	1.000	0.353	.047	6	view →
KIRP	OS	Tertile	All	0.714	0.907	.033	3	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

RNU6-794P–BRCA (DFS)

Open the BRCA breakdown →